Holds 4 active US DMFs and one valid CEP for lidocaine, filing since 2012. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds 4 active US DMFs and one valid CEP for lidocaine, filing since 2012. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs and 2 valid CEPs for lidocaine, filing since 2013. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 3 markets.
Holds 2 active US DMFs for lidocaine, filing since 2019. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Registered with SFDA (Saudi Arabia) for lidocaine. Its GMP is recognised in 9 markets.
Holds one valid CEP for lidocaine, filing since 2025.
Holds one active US DMF for lidocaine, filing since 2025.
Registered with SFDA (Saudi Arabia) for lidocaine.
Registered with SFDA (Saudi Arabia) for lidocaine.
Registered with SFDA (Saudi Arabia) for lidocaine.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
This page filters the worldwide Lidocaine manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free